These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36842188)

  • 21. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion.
    Bique C; Ustá M; Debora B; Chong E; Westheimer E; Winikoff B
    Int J Gynaecol Obstet; 2007 Sep; 98(3):222-6. PubMed ID: 17610879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda.
    Cleeve A; Byamugisha J; Gemzell-Danielsson K; Mbona Tumwesigye N; Atuhairwe S; Faxelid E; Klingberg-Allvin M
    PLoS One; 2016; 11(2):e0149172. PubMed ID: 26872219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.
    Weeks A; Alia G; Blum J; Winikoff B; Ekwaru P; Durocher J; Mirembe F
    Obstet Gynecol; 2005 Sep; 106(3):540-7. PubMed ID: 16135584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home self-administration of misoprostol for medical abortion up to 56 days' gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):189-92. PubMed ID: 16105279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial.
    Klingberg-Allvin M; Cleeve A; Atuhairwe S; Tumwesigye NM; Faxelid E; Byamugisha J; Gemzell-Danielsson K
    Lancet; 2015 Jun; 385(9985):2392-8. PubMed ID: 25817472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a training intervention in increasing the use of misoprostol in postabortion care in Malawi: a quasi-experimental study.
    Magreta Chakhame B; Darj E; Mwapasa M; Kafulafula U; Chiudzu G; Maluwa A; Malata A; Odland JØ; Odland ML
    BMJ Open; 2022 Dec; 12(12):e061886. PubMed ID: 36517095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya.
    Makenzius M; Oguttu M; Klingberg-Allvin M; Gemzell-Danielsson K; Odero TMA; Faxelid E
    BMJ Open; 2017 Oct; 7(10):e016157. PubMed ID: 29018067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
    Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study.
    Ani VC; Enebe JT; Dim CC; Dim NR; Ozumba BC
    Pan Afr Med J; 2022; 41():90. PubMed ID: 35432695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misoprostol versus manual vacuum aspiration for treatment of first-trimester incomplete miscarriage in a low-resource setting: A randomized controlled trial.
    Nwafor JI; Agwu UM; Egbuji CC; Ekwedigwe KC
    Niger J Clin Pract; 2020 May; 23(5):638-646. PubMed ID: 32367870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of incomplete abortion related to treatment modality.
    Sharvit M; Yagur Y; Shams R; Daykan Y; Klein Z; Schonman R
    Arch Gynecol Obstet; 2023 Nov; 308(5):1543-1548. PubMed ID: 37653249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care providers' perceptions of using misoprostol in the treatment of incomplete abortion in Malawi.
    Wagenheim CA; Savosnick H; Chakhame BM; Darj E; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
    BMC Health Serv Res; 2022 Dec; 22(1):1471. PubMed ID: 36461125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas.
    Johnson BR; Maksutova E; Boobekova A; Davletova A; Kazakbaeva C; Kondrateva Y; Landoulsi S; Lazdane G; Monolbaev K; Seuc Jo AH
    Contraception; 2018 Feb; 97(2):160-166. PubMed ID: 29133110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals.
    Dabash R; Ramadan MC; Darwish E; Hassanein N; Blum J; Winikoff B
    Int J Gynaecol Obstet; 2010 Nov; 111(2):131-5. PubMed ID: 20801444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misoprostol alone--a new method of medical abortion?
    Blanchard K; Winikoff B; Coyaji K; Nguyen TN
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):189-90. PubMed ID: 10846336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IS MISOPROSTOL A SUITABLE ALTERNATIVE TO THE SURGICAL EVACUATION OF INCOMPLETE ABORTION IN RURAL SOUTH-EASTERN NIGERIA?
    Chigbu B; Onwere S; Aluka C; Kamanu C; Ezenobi O
    East Afr Med J; 2012 May; 89(5):172-7. PubMed ID: 26875224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of incomplete abortion and miscarriage with misoprostol.
    Blum J; Winikoff B; Gemzell-Danielsson K; Ho PC; Schiavon R; Weeks A
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S186-9. PubMed ID: 17961569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.